Identification of CLEC10A as a human lectin for pancreatic ductal adenocarcinoma

Related articles

1. HPGDS as a biomarker for prognosis and immunotherapy in pancreatic cancer

   This article has 10 authors:

   1. Hao Ye
   2. Zhengyang Zhou
   3. Chenjun Xie
   4. Ge Gao
   5. Qingwen Wang
   6. Xiaoyun Wang
   7. Huaxin Kang
   8. Mengkui Han
   9. Xichen Wang
   10. Junjing Zhou

2. Concordance of claudin-18.2 expression in biopsy, resection, and recurrent specimens: implications for zolbetuximab therapy in pancreatic ductal adenocarcinoma

   This article has 7 authors:

   1. Daisuke Kyuno
   2. Kazuhiko Yanazume
   3. Akira Saito
   4. Yusuke Ono
   5. Tatsuya Ito
   6. Masafumi Imamura
   7. Makoto Osanai

3. High-Dimensional Protein Analysis Uncovers Distinct Immunological and Stromal Signatures Between Primary and Metastatic Pancreatic Ductal Adenocarcinoma

   This article has 20 authors:

   1. Emily Greene
   2. Natalie K. Horvat
   3. Deon B. Doxie
   4. Vaunita C. Parihar
   5. Jayden Kim
   6. Cameron J. Herting
   7. Erin E. Grundy
   8. Ayana T. Ruffin
   9. Alyssa M. Krasinskas
   10. Shishir K. Maithel
   11. Juan M. Sarmiento
   12. Mihir M. Shah
   13. Mohammad Y. Zaidi
   14. Maria Diab
   15. Olatunji B. Alese
   16. Kavita Dhodapkar
   17. Haydn T. Kissick
   18. Bassel F. El-Rayes
   19. Chrystal M. Paulos
   20. Gregory B. Lesinski